Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
A pharmaceutical care program for dyslipidemic patients was designed, implemented, and assessed. The study was conducted during 32 weeks, at three Primary Health Care Centers. One hundred and forty two patients were selected. These patients were randomly assigned to intervention or control groups. I...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | Articulo |
Lenguaje: | Inglés |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/7777 http://www.latamjpharm.org/trabajos/28/3/LAJOP_28_3_1_13_3854527IO1.pdf |
Aporte de: |
id |
I19-R120-10915-7777 |
---|---|
record_format |
dspace |
institution |
Universidad Nacional de La Plata |
institution_str |
I-19 |
repository_str |
R-120 |
collection |
SEDICI (UNLP) |
language |
Inglés |
topic |
Farmacia programa de cuidados farmaceúticos; centros primarios de salud; tratamiento y calidad de vida Farmacología Efecto de las drogas Efectos fisiológicos de las drogas pharmaceutical care program; primary health care centers; treatment and quality of life |
spellingShingle |
Farmacia programa de cuidados farmaceúticos; centros primarios de salud; tratamiento y calidad de vida Farmacología Efecto de las drogas Efectos fisiológicos de las drogas pharmaceutical care program; primary health care centers; treatment and quality of life Villa, Lorenzo A. Chrismar, Ana M. von Oyarzún, Carlos Eujenín, Paloma Fernández, María E. Quezada, Marcela Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes |
topic_facet |
Farmacia programa de cuidados farmaceúticos; centros primarios de salud; tratamiento y calidad de vida Farmacología Efecto de las drogas Efectos fisiológicos de las drogas pharmaceutical care program; primary health care centers; treatment and quality of life |
description |
A pharmaceutical care program for dyslipidemic patients was designed, implemented, and assessed. The study was conducted during 32 weeks, at three Primary Health Care Centers. One hundred and forty two patients were selected. These patients were randomly assigned to intervention or control groups. Intervention group patients received care twice a month and were surveyed to assess their knowledge about their illness and medications, adherence to drug therapy, and quality of life. Possible drug related problems (DRP) were identified, the most frequent being that medication was not taken according to medical indication. Total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides were measured every two months, with results showing significant improvements in the intervention group’s total cholesterol, LDL-cholesterol (p < 0.0001) and triglycerides (p = 0.009), knowledge of the illness (p < 0.0001), adherence to pharmacological treatment (p < 0.0001), and quality of life (p < 0.0001). Pharmaceutical care prevents and solves drug-related problems and improves patients’ clinical parameters, adherence to medical treatment and quality of life. |
format |
Articulo Articulo |
author |
Villa, Lorenzo A. Chrismar, Ana M. von Oyarzún, Carlos Eujenín, Paloma Fernández, María E. Quezada, Marcela |
author_facet |
Villa, Lorenzo A. Chrismar, Ana M. von Oyarzún, Carlos Eujenín, Paloma Fernández, María E. Quezada, Marcela |
author_sort |
Villa, Lorenzo A. |
title |
Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes |
title_short |
Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes |
title_full |
Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes |
title_fullStr |
Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes |
title_full_unstemmed |
Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes |
title_sort |
pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes |
publishDate |
2009 |
url |
http://sedici.unlp.edu.ar/handle/10915/7777 http://www.latamjpharm.org/trabajos/28/3/LAJOP_28_3_1_13_3854527IO1.pdf |
work_keys_str_mv |
AT villalorenzoa pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes AT chrismaranamvon pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes AT oyarzuncarlos pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes AT eujeninpaloma pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes AT fernandezmariae pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes AT quezadamarcela pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes |
bdutipo_str |
Repositorios |
_version_ |
1764820485071175681 |